Columbia-NYSPI-RFMH   Report issue

Academic/Hospital Phase 2
Founded: New York NY United States (1952)

Organization Overview

First Clinical Trial
2008
NCT00728923
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

ketamine (ketalar) (2 trials)

methylphenidate (ritalin) (1 trial)

npl-2003 (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Compulsive Personality Disorder (Phase 2)

Hoarding Disorder (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4